Cargando…
Progression of Impending Central Retinal Vein Occlusion to the Ischemic Variant Following Intravitreal Bevacizumab
A 60-year-old woman who had experienced two episodes of amaurosis fugax in her right eye presented with vision loss. Two weeks earlier, at a private clinic, she was diagnosed with impending central retinal vein occlusion (CRVO) of the right eye and received an intravitreal injection of bevacizumab....
Autores principales: | Kim, Na Rae, Chin, Hee Seung |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882084/ https://www.ncbi.nlm.nih.gov/pubmed/20532147 http://dx.doi.org/10.3341/kjo.2010.24.3.179 |
Ejemplares similares
-
Clinical Progress in Impending Central Retinal Vein Occlusion
por: Lee, Dong-Hoon, et al.
Publicado: (2010) -
Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion
por: Hall, Leangelo, et al.
Publicado: (2019) -
Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients
por: Isola, Vincenzo, et al.
Publicado: (2013) -
Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion
por: Nagpal, Manish, et al.
Publicado: (2011) -
Impending central retinal vein occlusion associated with cilioretinal artery obstruction
por: Bottós, Juliana Mantovani, et al.
Publicado: (2008)